Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01603992 · ClinicalTrials.gov registry record
Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms
A clinical trial of Cannabis Dependence and Cannabis Abuse, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 822
- Enrollment target
- 3
- Study locations
NCT01603992: Completed study of Cannabis Dependence and Cannabis Abuse, sponsored by National Institute on Drug Abuse (NIDA).
NCT01603992 is a study of Cannabis Dependence and Cannabis Abuse that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 822 participants, above the 62-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (1226% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01603992, a study of Cannabis Dependence and Cannabis Abuse, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 822 participants
- Enrollment target
- 3
- Study locations
Study Summary
Background: \- Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment ( spontaneous quitting). Studies have suggested that there are some common strategies that many individuals use in spontaneous quitting, such as changing one s lifestyle or identity, reminding oneself of negative consequences, support from family and friends, and religion. However, more research is needed to determine potential treatment strategies for marijuana use. Objectives: * To identify strategies used to help with marijuana quitting among non-treatment seeking adult marijuana users. * To identify withdrawal symptoms experienced during marijuana quitting and their relationship to the quitting strategies used and the outcome of the quit attempt. * To evaluate whether subgroups of marijuana users differ in their experience of marijuana quitting. Eligibility: \- Individuals at least 18 years of age who have made at least one attempt to quit marijuana use. Design: * The study will consist of one visit of approximately 1 to 2 hours. * Participants will fill out three questionnaires. The questionnaires have different types of questions, and will ask about background and lifestyle, marijuana use and craving patterns and behaviors, and difficulties in previous attempts to quit using marijuana.
Conditions Studied
Study Locations (3)
Maryland
- National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore
- Maryland Psychiatric Research Center (MPRC) 55 Wade Avenue - Catonsville
South Carolina
- Medical University of S. Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 822 participants |
| Start Date | 2005-11-08 |
| Est. Completion | 2012-05-03 |
What the finished NCT01603992 record still lists
NCT01603992 is an observational study that tracks outcomes without assigning an intervention. The registered 822 participants enrollment target is mid-sized for trials with a published cap, above the 62-participant average among 12 other Cannabis Dependence trials with a reported enrollment target (1226% higher).
The record links to 2 conditions, with Cannabis Dependence appearing as the primary indexed condition, and to 0 interventions.
NCT01603992 reports a single indexed study location in Maryland, South Carolina.
Frequently Asked Questions
What is clinical trial NCT01603992 about?
NCT01603992 is a clinical study titled "Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms". Background: \- Marijuana is the most widely used illicit drug in the world, yet relatively little is known about users who try to quit without formal treatment ( spontaneous quitting). Studies have suggested that there are some common strategies that many individuals use in spontaneous quitting, su...
What is the current status of trial NCT01603992?
This trial is currently completed. The enrollment target is 822 participants. The study started on 2005-11-08. Estimated completion is 2012-05-03.
What conditions does trial NCT01603992 study?
This clinical trial studies the following conditions: Cannabis Dependence, Cannabis Abuse.
Who is sponsoring clinical trial NCT01603992?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01603992 being conducted?
This trial has 3 study locations across Maryland, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01603992's enrollment target sits among peer trials
822 1st of 12 higher than 12 of 12 other Cannabis Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
RECRUITING
-
Neuroimaging of Adolescent Cannabis Use Treatment
RECRUITING · NA
-
Breathwork-assisted Treatment for Cannabis Use Disorder
ACTIVE NOT RECRUITING · NA
-
Improving Substance Use and Clinical Outcomes in Heavy Cannabis Users With Quetiapine
COMPLETED · Phase 4
-
Targeting Tobacco Cessation During Treatment for Cannabis Use Disorders
COMPLETED · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05679349 · 822 participants · NA
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
- NCT06091254 · 822 participants · Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
- NCT07357389 · 822 participants · NA
Virtual Reality for ICU Delirium Prevention
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI